BECN1 and diffuse large B-cell lymphoma: Taken together, our data indicate that autophagy modulation significantly affects the outcome of chemotherapy, and we conclude that BECLIN-1-dependent autophagy is associated with improved therapeutic efficacy in patients with DLBCL, strongly supporting BECLIN-1 as a positive prognostic marker.